LUMOS PHARMA, INC. Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Lumos Pharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
  • Lumos Pharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $387K, a 40.7% decline year-over-year.
  • Lumos Pharma, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $2.05M, a 15.3% decline year-over-year.
  • Lumos Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2.32M, a 0.09% increase from 2022.
  • Lumos Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.32M, a 19.4% decline from 2021.
  • Lumos Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.88M, a 168% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.32M +$2K +0.09% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $2.32M -$559K -19.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $2.88M +$1.81M +168% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-07
2020 $1.07M +$895K +500% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 $179K -$16.9M -99% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
2018 $17.1M -$1.4M -7.57% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-03
2017 $18.5M +$1.8M +10.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-03
2016 $16.7M +$800K +5.03% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-05
2015 $15.9M +$7.3M +84.9% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-05
2014 $8.6M +$4.2M +95.5% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-06
2013 $4.4M +$1.2M +37.5% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 $3.2M +$700K +28% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-16
2011 $2.5M +$1M +66.7% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-12
2010 $1.5M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.